scholarly journals Recent progress in materials development for CO2 conversion: issues and challenges

2021 ◽  
Author(s):  
Sourav Ghosh ◽  
Arindam Modak ◽  
Arnab Samanta ◽  
Kanika Kole ◽  
Subhra Jana

A comprehensive and critical in-depth discussion on the development and prospect of several advanced materials for conversion of CO2 to value added chemicals is provided, together with their current status, technical feasibility and future opportunities.

1986 ◽  
Vol 10 (3P2A) ◽  
pp. 728-733 ◽  
Author(s):  
G.E. Lucas ◽  
G.R. Odette ◽  
J.W. Sheckherd ◽  
M.R. Krishnadev

2015 ◽  
Vol 10 (3) ◽  
pp. 546-555 ◽  
Author(s):  
M. Arcos-Hernández ◽  
L. Montaño-Herrera ◽  
O. Murugan Janarthanan ◽  
L. Quadri ◽  
S. Anterrieu ◽  
...  

Pilot and prototyping scale investigations were undertaken in order to evaluate the technical feasibility of producing value-added biopolymers (polyhydroxyalkanoates (PHAs)) as a by-product to essential services of wastewater treatment and environmental protection. A commonly asked question concerns PHA quality that may be expected from surplus biomass produced during biological treatment for water quality improvement. This paper summarizes the findings from a collection of investigations. Alongside the summarized technical efforts, attention has been paid to the social and economic networks. Such networks are needed in order to nurture circular economies that would drive value chains in renewable resource processing from contaminated water amelioration into renewable value-added bioplastic products and services. We find commercial promise in the polymer quality and in the process technical feasibility. The next challenge ahead does not reside so much any more in fundamental research and development of the technology but, rather, in social-economic steps that will be necessary to realize first demonstration scale polymer production activities. It is a material supply that will stimulate niche business opportunities that can grow and stimulate technology pull with benefit of real life material product market combinations.


2017 ◽  
Vol 46 (19) ◽  
pp. 5805-5863 ◽  
Author(s):  
Ramses Snoeckx ◽  
Annemie Bogaerts

Plasma technology as a potential breakthrough technology for the economic conversion of CO2 into value-added chemicals and fuels.


2015 ◽  
Vol 2 (3) ◽  
pp. 1-19 ◽  
Author(s):  
Steve Bin Zhou ◽  
Fiona Xiaoying Ji

Lean is a systematic approach to identify and eliminate non-value-added activities or waste through continuous improvement process. While traditional lean manufacturing focuses on the activities within a single organization, lean supply chain consists of the same processes, but it views these processes over multiple organizations. This research addresses an important yet under-studied area – lean supply chain management in small organizations, especially small manufacturing firms. The study examines driving factors of lean supply chain management, focus of lean supply chain practices, and major supply chain and information technology solutions applied in these companies. Through a research survey, the study has provided important insights into the current status of lean supply chain practices and related implementation issues in small businesses.


2010 ◽  
Vol 3 (7) ◽  
pp. 884 ◽  
Author(s):  
Robert W. Dorner ◽  
Dennis R. Hardy ◽  
Frederick W. Williams ◽  
Heather D. Willauer

Pathogens ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 405 ◽  
Author(s):  
Hany M. Elsheikha ◽  
Ruqaiyyah Siddiqui ◽  
Naveed Ahmed Khan

Although major strides have been made in developing and testing various anti-acanthamoebic drugs, recurrent infections, inadequate treatment outcomes, health complications, and side effects associated with the use of currently available drugs necessitate the development of more effective and safe therapeutic regimens. For any new anti-acanthamoebic drugs to be more effective, they must have either superior potency and safety or at least comparable potency and an improved safety profile compared to the existing drugs. The development of the so-called ‘next-generation’ anti-acanthamoebic agents to address this challenge is an active area of research. Here, we review the current status of anti-acanthamoebic drugs and discuss recent progress in identifying novel pharmacological targets and new approaches, such as drug repurposing, development of small interfering RNA (siRNA)-based therapies and testing natural products and their derivatives. Some of the discussed approaches have the potential to change the therapeutic landscape of Acanthamoeba infections.


Sign in / Sign up

Export Citation Format

Share Document